Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel-Reference-Cited by-同舟云学术

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel

Published:2015-02 Issue:1 Volume:15 Page:16-23
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Bria Emilio,Furlanetto Jenny,Carbognin Luisa,Brunelli Matteo,Caliolo Chiara,Nortilli Rolando,Massari Francesco,Pedron Serena,Manfrin Erminia,Pellini Francesca,Bonetti Franco,Sperduti Isabella,Pollini Giovanni Paolo,Scarpa Aldo,Tortora Giampaolo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

2. Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials;Cuppone;Cancer,2008

3. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis;Mauri;J Natl Cancer Inst,2005

4. Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials;Bria;Breast Cancer Res Treat,2008

5. Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues;Bria;Expert Opin Biol Ther,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing Biomarkers for Predicting Pathological Responses to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-10-28

2. Treatment outcomes among human epidermal growth factor receptor 2 positive breast cancer patients: A systematic review;Journal of Oncology Pharmacy Practice;2021-03-31

3. Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy;Scientific Reports;2020-09-23

4. SIRT1 activation mediates heat-induced survival of UVB damaged Keratinocytes;BMC Dermatology;2017-06-10

5. The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis;Future Oncology;2017-04